Indinavir Sulfate Patent Expiration
Indinavir Sulfate is Used for managing HIV infection when used in combination with other antiretroviral agents. It was first introduced by Merck Sharp And Dohme Corp
Indinavir Sulfate Patents
Given below is the list of patents protecting Indinavir Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Crixivan | US6689761 | Combination therapy for HIV infection |
Feb 10, 2021
(Expired) | Merck Sharp Dohme |
| Crixivan | US6645961 | Dry granulation formulation for an HIV protease inhibitor |
Mar 04, 2018
(Expired) | Merck Sharp Dohme |
Indinavir Sulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List